![](/img/cover-not-exists.png)
Potential clinical and immunotherapeutic utility of talimogene laherparepvec for patients with melanoma after disease progression on immune checkpoint inhibitors and BRAF inhibitors
Chesney, Jason, Imbert-Fernandez, Yoannis, Telang, Sucheta, Baum, Mary, Ranjan, Smita, Fraig, Mostafa, Batty, NicolasLanguage:
english
Journal:
Melanoma Research
DOI:
10.1097/CMR.0000000000000444
Date:
March, 2018
File:
PDF, 243 KB
english, 2018